These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27923518)

  • 1. The Impact of Emerging Infectious Diseases on Chinese Blood Safety.
    He M; Wang J; Chen L; Liu J; Zeng P
    Transfus Med Rev; 2017 Apr; 31(2):94-101. PubMed ID: 27923518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus.
    Kiely P; Wood EM; Gambhir M; Cheng AC; McQuilten ZK; Seed CR
    Med J Aust; 2017 Jun; 206(10):455-460. PubMed ID: 28566073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
    Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
    Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.
    Kiely P; Gambhir M; Cheng AC; McQuilten ZK; Seed CR; Wood EM
    Transfus Med Rev; 2017 Jul; 31(3):154-164. PubMed ID: 28545882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into "Calculated Risk": An Application to the Prioritization of Emerging Infectious Diseases for Blood Transfusion Safety.
    Neslo REJ; Oei W; Janssen MP
    Risk Anal; 2017 Sep; 37(9):1783-1795. PubMed ID: 28229466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
    Glynn SA; Busch MP; Dodd RY; Katz LM; Stramer SL; Klein HG; Simmons G; Kleinman SH; Shurin SB;
    Transfusion; 2013 Feb; 53(2):438-54. PubMed ID: 22690676
    [No Abstract]   [Full Text] [Related]  

  • 8. Modeling the risk of an emerging pathogen entering the Canadian blood supply.
    Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D
    Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections.
    Stramer SL
    ISBT Sci Ser; 2014 Jul; 9(1):30-36. PubMed ID: 25210533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
    JAMA; 1995 Nov; 274(17):1374-9. PubMed ID: 7563563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 13. Babesia: an emerging infectious threat in transfusion medicine.
    Lobo CA; Cursino-Santos JR; Alhassan A; Rodrigues M
    PLoS Pathog; 2013; 9(7):e1003387. PubMed ID: 23853577
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.
    Bloch EM; Vermeulen M; Murphy E
    Transfus Med Rev; 2012 Apr; 26(2):164-80. PubMed ID: 21872426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers.
    Whitaker BI; Walderhaug M; Hinkins S; Steele WR; Custer B; Kessler D; Leparc G; Gottschall JL; Bialkowski W; Stramer SL; Dodd RY; Crowder L; Vahidnia F; Shaz BH; Kamel H; Rebosa M; Stern M; Anderson SA
    Transfusion; 2020 Sep; 60(9):1987-1997. PubMed ID: 32743798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential threat to blood transfusion safety of emerging infectious disease agents.
    Stramer SL
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):420-2. PubMed ID: 26353036
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
    Atreya C; Nakhasi H; Mied P; Epstein J; Hughes J; Gwinn M; Kleinman S; Dodd R; Stramer S; Walderhaug M; Ganz P; Goodrich R; Tibbetts C; Asher D
    Transfusion; 2011 Aug; 51(8):1855-71. PubMed ID: 21392016
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood transfusion and infectious diseases].
    Hamaguchi I
    Rinsho Byori; 2013 May; 61(5):414-7. PubMed ID: 23947180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging pathogens in transfusion medicine.
    Dodd RY
    Clin Lab Med; 2010 Jun; 30(2):499-509. PubMed ID: 20513567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.
    Bloch EM; Busch MP; Corash LM; Dodd R; Hailu B; Kleinman S; O'Brien S; Petersen L; Stramer SL; Katz L
    Transfus Med Rev; 2023 Oct; 37(4):150769. PubMed ID: 37919210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.